Bank Of Montreal Immunity Bio, Inc. Transaction History
Bank Of Montreal
- $202 Billion
- Q4 2024
A detailed history of Bank Of Montreal transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 3,200 shares of IBRX stock, worth $11,584. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,200
Previous 2,500
28.0%
Holding current value
$11,584
Previous $9,000
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IBRX
# of Institutions
228Shares Held
82.2MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$62.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$41.4 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$35.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$14.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$13.9 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.45B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...